Saif, Muhammad. 2013. “U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination With Gemcitabine As First-Line Treatment of Patients With Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas 14 (6), 686-88. https://doi.org/10.6092/1590-8577/2028.